This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Haibo Xie: Innovator in Pharmaceutical Chemistry
Introduction
Haibo Xie is a prominent inventor based in Madison, WI (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific health conditions.
Latest Patents
Haibo Xie holds a patent for "Benzoimidazole indolyl methanes and methods of using them to inhibit PCSK9 and PCSK9-mediated ailments." This patent describes benzoimidazole indolyl methane compounds, pharmaceutical compositions containing them, and their use in inhibiting ailments mediated by PCSK9. The innovative compounds developed by Xie have the potential to address critical health issues.
Career Highlights
Xie is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and development efforts. His work has led to the creation of valuable pharmaceutical solutions that can improve patient outcomes.
Collaborations
Throughout his career, Haibo Xie has collaborated with notable colleagues, including Weiping Tang and Gabrielle N. Winston-McPherson. These partnerships have fostered a collaborative environment that enhances innovation and research.
Conclusion
Haibo Xie's contributions to pharmaceutical chemistry and his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the treatment of PCSK9-mediated ailments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile